Phibro Anl Htlh A (PAHC) Stock Price, Quote & News

Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, su...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 201 329 7300

Website: www.pahc.com

Address:

Glenpointe Centre East, 3rd Floor Suite 21 300 Frank West Burr Boulevard, Teaneck, United States

MarketBeat May. 8 at 8:03 PM

Phibro Animal Health Q3 Earnings Call Highlights $PAHC #PhibroAnimalHealth #instantalerts #NASDAQ:PAHC https://www.marketbeat.com/instant-a

0 · Reply

SuperGreenToday May. 6 at 10:18 PM

$PAHC Share Price: $58.67 Contract Selected: Dec 18, 2026 $60 Calls Buy Zone: $5.70 – $7.04 Target Zone: $9.15 – $11.18 Potential Upside: 52% ROI Time to Expiration: 225 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

StocktwitsEarnings May. 6 at 8:35 PM

$PAHC Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.59 up 13.46% YoY • Reported revenue of $383.54M up 10.27% YoY

0 · Reply

OfficialStocktwitsUser Apr. 27 at 8:07 PM

$PAHC RSI: 51.17, MACD: 0.5730 Vol: 1.92, MA20: 56.01, MA50: 53.67 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

TheBehavioralTrader Apr. 9 at 10:48 AM

$PAHC working in from the low 52-53 range in the swing service last week we sold half yesterday in the 58s per rules holding half still

0 · Reply

kiwitc2000 Mar. 25 at 8:23 PM

$PAHC Still going strong, good fundamentals. Adding.

0 · Reply

Doozio Mar. 23 at 11:41 PM

$PAHC da huckleberries are thru da $$$$$

0 · Reply

ZacksResearch Mar. 12 at 1:14 PM

$PAHC surges 126.9% in the past year – What’s driving this Zacks Rank #1 stock? 🚀 🐾 Strong animal health portfolio + Zoetis integration 💉 Vaccine sales up 13% in the second quarter of fiscal 2026, boosted by Latin America demand 💰 Robust solvency with strategic buybacks & dividends Discover why PAHC is a top pick 👉 https://www.zacks.com/stock/news/2882847/is-pahc-stock-a-solid-investment-opportunity-right-now?cid=sm-stocktwits-2-2882847-body-37109&ADID=SYND_STOCKTWITS_TWEET_2_2882847_BODY_37109

0 · Reply

ZacksResearch Mar. 12 at 12:14 PM

Is $PAHC a hidden opportunity… or a value trap right now? A closer look is being made into whether the stock truly represents a solid investment opportunity at current levels — a question many investors are asking as they evaluate its risk/reward profile. ⚖️ Full investment breakdown here 👉 https://www.zacks.com/stock/news/2882847/is-pahc-stock-a-solid-investment-opportunity-right-now?cid=sm-stocktwits-2-2882847-teaser-37095&ADID=SYND_STOCKTWITS_TWEET_2_2882847_TEASER_37095

0 · Reply

BillionerOfKing Feb. 20 at 12:52 PM

$PAHC Current Stock Price: $51.87 Contracts to trade: $50.0 PAHC Feb 20 2026 Call Entry: $2.66 Exit: $3.88 ROI: 46% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference

May 7, 2026, 9:00 AM EDT - 6 days ago

Phibro Animal Health Earnings Call Transcript: Q3 2026

2026-05-07T01:10:38.000Z - 6 days ago

Phibro Animal Health reports Q3 adjusted EPS 76c, consensus 71c

2026-05-07T01:09:39.000Z - 6 days ago

Phibro Animal Health raises FY26 EPS view to $2.98-$3.10 to $2.93-$3.10

May 6, 2026, 4:30 PM EDT - 6 days ago

Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance

May 5, 2026, 4:30 PM EDT - 7 days ago

Phibro Animal Health Corporation Declares Quarterly Dividend

May 5, 2026, 4:15 PM EDT - 7 days ago

Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership

Apr 29, 2026, 4:30 PM EDT - 13 days ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

2026-04-27T20:43:56.000Z - 15 days ago

Phibro Animal Health discloses new framework on antimicrobials in Brazil

Apr 27, 2026, 4:30 PM EDT - 15 days ago

Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials

2026-04-15T10:26:48.000Z - 4 weeks ago

Phibro Animal Health initiated with a Neutral at Citi

Feb 26, 2026, 10:45 AM EST - 2 months ago

Phibro Animal Health Transcript: BofA Securities Animal Health Summit

Feb 18, 2026, 4:30 PM EST - 2 months ago

Phibro Animal Health Corporation to Participate in Bank of America 2026 Virtual Animal Health Summit

2026-02-06T16:00:22.000Z - 3 months ago

Phibro Animal Health price target raised to $49 from $45 at Morgan Stanley

Feb 5, 2026, 9:00 AM EST - 3 months ago

Phibro Animal Health Earnings Call Transcript: Q2 2026

2026-02-04T21:31:15.000Z - 3 months ago

Phibro Animal Health reports Q2 adjusted EPS 87c, consensus 67c

2026-02-04T21:30:47.000Z - 3 months ago

Phibro Animal Health raises FY26 EPS view to $2.93-$3.10 from $2.64-$2.81

Feb 4, 2026, 4:25 PM EST - 3 months ago

Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance

Jan 28, 2026, 4:30 PM EST - 3 months ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results

2025-12-18T21:15:43.000Z - 5 months ago

Phibro Animal Health says Daniel Bendheim to assume CEO role in July

Dec 18, 2025, 4:10 PM EST - 5 months ago

Phibro Animal Health Corporation Announces Leadership Transition

2025-11-07T18:40:17.000Z - 6 months ago

Phibro Animal Health price target raised to $45 from $34 at Morgan Stanley

2025-11-07T12:50:48.000Z - 6 months ago

Phibro Animal Health price target raised to $50 from $45 at JPMorgan

Nov 6, 2025, 9:00 AM EST - 6 months ago

Phibro Animal Health Earnings Call Transcript: Q1 2026

2025-11-05T23:11:05.000Z - 6 months ago

Phibro Animal Health reports Q1 EPS 73c, consensus 60c

2025-11-05T23:10:47.000Z - 6 months ago

Phibro Animal Health sees FY26 EPS $2.64-$2.81, consensus $2.63

Nov 5, 2025, 4:22 PM EST - 6 months ago

Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance

2025-10-30T17:05:17.000Z - 6 months ago

Phibro Animal Health announces national launch of Restoris dental gel

Oct 30, 2025, 1:00 PM EDT - 6 months ago

Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs

Oct 29, 2025, 4:00 PM EDT - 6 months ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results

2025-10-09T20:35:48.000Z - 7 months ago

Phibro Animal Health announces licensing pact with Lighthouse Pharmaceuticals

Oct 9, 2025, 4:30 PM EDT - 7 months ago

Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs

Sep 9, 2025, 12:20 PM EDT - 8 months ago

Phibro Animal Health Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

2025-09-04T18:00:13.000Z - 8 months ago

Phibro price target raised to $37 from $24 at BNP Paribas Exane

Sep 2, 2025, 4:00 PM EDT - 9 months ago

Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference

2025-08-29T12:50:31.000Z - 9 months ago

Phibro Animal Health price target raised to $27 from $19 at BofA

2025-08-28T15:30:14.000Z - 9 months ago

Phibro Animal Health price target raised to $34 from $26 at Morgan Stanley

Aug 28, 2025, 9:00 AM EDT - 9 months ago

Phibro Animal Health Earnings Call Transcript: Q4 2025

2025-08-27T21:05:16.000Z - 9 months ago

Phibro Animal Health sees FY26 EPS $2.52-$2.70, consensus $2.32

2025-08-27T21:00:22.000Z - 9 months ago

Phibro Animal Health reports Q4 EPS 57c, consensus 52c

Aug 27, 2025, 4:57 PM EDT - 9 months ago

Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance

Aug 20, 2025, 4:00 PM EDT - 9 months ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results

Jul 7, 2025, 5:00 PM EDT - 11 months ago

Overlooked Stock: PAHC Taps 4-Year High

2025-07-07T08:55:06.000Z - 11 months ago

Phibro Animal Health upgraded to Overweight from Neutral at JPMorgan

May 29, 2025, 8:35 AM EDT - 1 year ago

Phibro Animal Health Transcript: Stifel Jaws & Paws Conference 2025

May 22, 2025, 4:00 PM EDT - 1 year ago

Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference

May 8, 2025, 9:00 AM EDT - 1 year ago

Phibro Animal Health Earnings Call Transcript: Q3 2025

Mar 13, 2025, 9:00 AM EDT - 1 year ago

Phibro Animal Health Transcript: Barclays 27th Annual Global Healthcare Conference

Mar 5, 2025, 4:00 PM EST - 1 year ago

Phibro Animal Health Corporation to Participate at Barclays Annual Global Healthcare Conference

Feb 20, 2025, 4:00 PM EST - 1 year ago

Phibro Animal Health Corporation to Participate at Bank of America 2025 Virtual Animal Health Summit

Feb 6, 2025, 9:00 AM EST - 1 year ago

Phibro Animal Health Earnings Call Transcript: Q2 2025

Jan 23, 2025, 4:45 PM EST - 1 year ago

Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors

Nov 7, 2024, 9:00 AM EST - 1 year ago

Phibro Animal Health Earnings Call Transcript: Q1 2025

Oct 31, 2024, 4:10 PM EDT - 1 year ago

Phibro Animal Health Corporation Completes Acquisition of Zoetis' Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products

ZTS

Sep 5, 2024, 1:05 PM EDT - 1 year ago

Phibro Animal Health Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 29, 2024, 9:00 AM EDT - 1 year ago

Phibro Animal Health Earnings Call Transcript: Q4 2024

Aug 14, 2024, 4:00 PM EDT - 1 year ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2024 Results

Jun 5, 2024, 4:00 PM EDT - 2 years ago

Phibro Animal Health Corporation Releases Third Annual ESG Report: Connections that Advance Animal Health, Nutrition and Sustainability

May 29, 2024, 10:20 AM EDT - 2 years ago

Phibro Animal Health Transcript: Stifel Jaws & Paws Conference

May 20, 2024, 4:00 PM EDT - 2 years ago

Phibro Animal Health Corporation to Participate in Stifel Dental and Animal Health (Jaws & Paws) Conference

May 9, 2024, 9:00 AM EDT - 2 years ago

Phibro Animal Health Earnings Call Transcript: Q3 2024

Apr 29, 2024, 8:30 AM EDT - 2 years ago

Phibro Animal Health Transcript: M&A Announcement

Apr 28, 2024, 6:30 PM EDT - 2 years ago

Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health

ZTS

Mar 12, 2024, 4:35 PM EDT - 2 years ago

Phibro Animal Health Transcript: Barclays 26th Annual Global Healthcare Conference 2024

Feb 29, 2024, 4:00 PM EST - 2 years ago

Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference

Feb 29, 2024, 10:00 AM EST - 2 years ago

Phibro Animal Health Transcript: Bank of America 2024 Animal Health Summit

Feb 14, 2024, 4:00 PM EST - 2 years ago

Phibro Animal Health Corporation to Participate in Bank of America 2024 Animal Health Summit

Feb 8, 2024, 9:00 AM EST - 2 years ago

Phibro Animal Health Earnings Call Transcript: Q2 2024

Feb 6, 2024, 8:30 AM EST - 2 years ago

Phibro Animal Health Corporation Announces Chief Financial Officer Changes

Nov 9, 2023, 9:00 AM EST - 2 years ago

Phibro Animal Health Earnings Call Transcript: Q1 2024

Nov 7, 2023, 10:23 AM EST - 2 years ago

Phibro Animal Health Corporation Reiterates Safety of Mecadox® and Intent to Defend its Use for Customers

Aug 31, 2023, 9:00 AM EDT - 2 years ago

Phibro Animal Health Earnings Call Transcript: Q4 2023

Jul 31, 2023, 4:00 PM EDT - 3 years ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2023 Results

May 9, 2023, 7:20 PM EDT - 3 years ago

Phibro Animal Health Transcript: Bank of America Global Healthcare Conference 2023

May 8, 2023, 4:01 PM EDT - 3 years ago

Phibro Issues Second Environmental, Social and Governance Report

May 4, 2023, 9:00 AM EDT - 3 years ago

Phibro Animal Health Earnings Call Transcript: Q3 2023

May 3, 2023, 4:30 PM EDT - 3 years ago

Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results

Apr 13, 2023, 4:00 PM EDT - 3 years ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Financial Results

Apr 5, 2023, 4:00 PM EDT - 3 years ago

Phibro Animal Health Corporation to Participate in Bank of America Securities 2023 Health Care Conference.

Mar 2, 2023, 10:50 AM EST - 3 years ago

Phibro Animal Health Transcript: Bank of America Animal Health Summit

Feb 14, 2023, 4:00 PM EST - 3 years ago

Phibro Animal Health Corporation to Participate in Bank of America 2023 Animal Health Summit

Feb 9, 2023, 9:00 AM EST - 3 years ago

Phibro Animal Health Earnings Call Transcript: Q2 2023

Feb 8, 2023, 4:35 PM EST - 3 years ago

Phibro Animal Health Corporation Reports Second Quarter Results

Feb 6, 2023, 4:15 PM EST - 3 years ago

Phibro Animal Health Corporation Announces the Appointment of Alejandro Bernal to Its Board of Directors and Declares Quarterly Dividend

Jan 9, 2023, 5:00 PM EST - 3 years ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2022 Quarterly Financial Results

Nov 10, 2022, 8:30 AM EST - 3 years ago

Phibro Animal Health Earnings Call Transcript: Q1 2023

Nov 9, 2022, 4:25 PM EST - 3 years ago

Phibro Animal Health Corporation Reports First Quarter Results, Revised Guidance

Oct 3, 2022, 5:00 PM EDT - 3 years ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2022 Quarterly Financial Results

Sep 19, 2022, 2:06 PM EDT - 3 years ago

The Carbon Trust Validates Greenhouse Gas Effects of Phibro Feed Additive

Sep 2, 2022, 2:12 PM EDT - 4 years ago

5 Pet Care Stocks Gurus Love

ELAN FRPT IDXX ZTS

Aug 25, 2022, 8:15 AM EDT - 4 years ago

Phibro Animal Health Earnings Call Transcript: Q4 2022

Aug 15, 2022, 5:00 PM EDT - 4 years ago

Phibro Animal Health Corporation to Participate in Morgan Stanley Global Healthcare Conference

Jul 27, 2022, 5:00 PM EDT - 4 years ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2022 Results

Jun 22, 2022, 8:00 AM EDT - 4 years ago

Phibro Animal Health Corporation and Rejuvenate Bio Announce Agreement to Develop Gene Therapy for Mitral Valve Disease in Canines

Jun 9, 2022, 3:30 PM EDT - 4 years ago

Phibro Issues Inaugural Environmental, Social and Governance Report

May 5, 2022, 9:11 AM EDT - 4 years ago

Phibro Animal Health Earnings Call Transcript: Q3 2022

May 4, 2022, 4:25 PM EDT - 4 years ago

Phibro Animal Health Corporation Reports Third Quarter Results, Provides Revised Financial Guidance

Apr 4, 2022, 5:00 PM EDT - 4 years ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2022 Quarterly Financial Results

MarketBeat May. 8 at 8:03 PM

Phibro Animal Health Q3 Earnings Call Highlights $PAHC #PhibroAnimalHealth #instantalerts #NASDAQ:PAHC https://www.marketbeat.com/instant-a

0 · Reply

SuperGreenToday May. 6 at 10:18 PM

0 · Reply

StocktwitsEarnings May. 6 at 8:35 PM

$PAHC Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.59 up 13.46% YoY • Reported revenue of $383.54M up 10.27% YoY

0 · Reply

OfficialStocktwitsUser Apr. 27 at 8:07 PM

0 · Reply

TheBehavioralTrader Apr. 9 at 10:48 AM

$PAHC working in from the low 52-53 range in the swing service last week we sold half yesterday in the 58s per rules holding half still

0 · Reply

kiwitc2000 Mar. 25 at 8:23 PM

$PAHC Still going strong, good fundamentals. Adding.

0 · Reply

Doozio Mar. 23 at 11:41 PM

$PAHC da huckleberries are thru da $$$$$

0 · Reply

ZacksResearch Mar. 12 at 1:14 PM

0 · Reply

ZacksResearch Mar. 12 at 12:14 PM

0 · Reply

BillionerOfKing Feb. 20 at 12:52 PM

0 · Reply

OfficialStocktwitsUser Feb. 17 at 4:12 PM

$PAHC RSI: 82.80, MACD: 3.3780 Vol: 5.78, MA20: 45.00, MA50: 41.55 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

OfficialStocktwitsUser Feb. 7 at 1:36 AM

$PAHC RSI: 78.38, MACD: 1.8619 Vol: 3.60, MA20: 41.48, MA50: 40.36 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Bigeyes2 Feb. 6 at 1:05 AM

$PAHC cup and handle but 5th wave

0 · Reply

Godwins26 Feb. 5 at 9:03 PM

Watchlist for the week $XTKG It's time 😊 $SITM $KELYB $PAHC $KLIC

0 · Reply

topstockalerts Feb. 5 at 4:46 PM

$PAHC Big move developing as buyers pile in 😮. Price is moving with force. This is real momentum.

0 · Reply

OldManGrumble Feb. 4 at 10:54 PM

$PAHC

0 · Reply

StocktwitsEarnings Feb. 4 at 9:25 PM

$PAHC Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.68 up 750.00% YoY • Reported revenue of $373.91M up 20.90% YoY

0 · Reply

EntropyX Feb. 4 at 1:46 PM

$PAHC is an animal health company focused on vaccines and pharmaceuticals; demand is stable, but growth is modest and competition from large players is significant.

0 · Reply

OldManGrumble Feb. 2 at 4:20 AM

$PAHC Good business

0 · Reply

ZacksResearch Jan. 28 at 12:54 PM

$PAHC set for Q2 growth — are expectations too high? 🚀 📈 Zacks Consensus Estimate points to 27.8% EPS growth YoY 🐾 Animal Health segment bolstered by Zoetis integration & new product launches 📉 But Mineral Nutrition sales could dip 8.7% YoY Opportunity assessment here 👉 https://www.zacks.com/stock/news/2824040/pahc-q2-earnings-preview-animal-health-momentum-likely-to-aid-results?cid=sm-stocktwits-2-2824040-body-30591&ADID=SYND_STOCKTWITS_TWEET_2_2824040_BODY_30591

0 · Reply

Market Cap	1.47B
Revenue (ttm)	1.30B
Net Income (ttm)	48.26M
EPS (ttm)	N/A
PE Ratio	13.65
Forward PE	13.09
Profit Margin	3.72%
Debt to Equity Ratio	2.03

Volume	471,000
Avg Vol	341,900
Day's Range	N/A - N/A
Shares Out	40.54M
Stochastic %K	6%
Beta	0.61
Analysts	Sell
Price Target	$48.80